ClavystBio — Full Portfolio

Leyden Labs develops nasal sprays containing antibodies that target respiratory viruses such as influenza and COVID at the nasal mucosa to prevent initial infection and transmission.

BiotechDeep TechHealthtechLeiden, NL

Koenraad Wiedhaup(Founder & Chief Executive Officer)inRonald Brus(Founder & Chief Growth Officer)inJaap Goudsmit(Founding Scientist and Senior Advisor)inDinko Valerio(Founder and Chair of the Supervisory Board)Jintanat Ananworanich(Chief Medical Officer)inClarissa Koch(Chief Scientific Officer)

Co-investorsF-Prime CapitalGV (Google Ventures)Bluebird VenturesCasdin CapitalEuropean Innovation Council FundEuropean Investment Bank+5 more

65LAB accelerates drug discovery and therapeutic company formation by connecting academic research institutions, life science investors, and Evotec to develop novel medicines into commercial entities.

BiotechDeep TechSingapore, SG

BoardSteve Courtney(Expert in Residence)

Co-investorsLightstone VenturesLeaps by Bayer

Allay Therapeutics develops localized pain management technology designed to deliver several weeks of post-surgical pain relief.

BiotechHealthtechMedical DevicesSan Jose, US

Adam Gridley(Executive Officer, Director)inKristen Howells(Executive Officer)inJosh Makower(Director)Tak Cheung(Director)Karun D. Naga(Executive Officer, Director)

BoardLeighton Read(Director)

Co-investorsArboretum VenturesLightstone VenturesNew Enterprise Associates (NEA)SGInnovate

Automera develops an autophagy-powered small molecule degrader platform designed to accelerate drug development and reduce costs in therapeutic creation.

AI & Machine LearningBiotechDeep Tech

Zian-Loong Wang(Chief Technology Officer & Co-Founder)Michael Lazarou(Co-Founder)inThong Q. Le(Chief Executive Officer)in

Co-investorsACCELERATOR LIFE SCIENCE PARTNERSXora Innovation Pte Ltd

Seattle and Singapore-based biotech developing next-generation multi-payload antibody-drug conjugates for cancer treatment.

Co-investorsFrazier Life SciencesJeito CapitalNorwest Venture PartnersPureos Bioventures

Ocular immunology-focused biotech developing cell and gene therapies for age-related macular degeneration and other chronic blinding diseases.

Biotech company developing booster vaccines and therapeutics against SARS-2 beta coronavirus variants.

Droia Ventures is a specialist venture capital firm investing globally in early-stage drug development companies focused on therapeutics for oncology and genetic disease.

BiotechLeuven, BE

Co-investorsFrazier Life SciencesLifeArc VenturesNovo Holdings

Singapore and US-based precision medicine biotech using machine learning and experimental biology to develop cancer and disease therapies.

Hummingbird Bioscience is a precision biotherapeutics company developing a pipeline of novel targeted therapies for cancer, using proprietary drug discovery technologies and platforms.

AI & Machine LearningBiotechDeep TechHealthtech

Piers Ingram(Chief Executive Officer, Co-Founder, Executive Director)Jerome Boyd-Kirkup(Chief Scientific Officer, Co-Founder)Konrad Paszkiewicz(Chief Technology Officer)inKwek Kon Yew(Chief Medical Officer)Dipti Thakkar(Chief Operating Officer)in

Co-investorsAltium CapitalDecheng CapitalDroia VenturesFrazier Life SciencesKiwoom InvestmentMuirwoods Ventures+2 more

Global venture capital firm investing in early-stage and opportunistic late-stage therapeutic and life science companies.

Singapore-based immune engineering company developing novel cellular therapies for T-cell malignancies and autoimmune diseases.

Singapore

Co-investorsLightstone VenturesOUP (Osage University Partners)

NSG Bio operates BSL-2 certified co-working wet-laboratory and office spaces for life sciences and biotech companies in Singapore, offering turnkey facilities, shared equipment, and support services for startups and multinationals conducting R&D.

BiotechPropTechSingapore, SG

Daphne Teo(Founder)in

Co-investorsNSG Ventures

Nuevocor is a biotechnology company developing gene therapy treatments for cardiovascular and metabolic diseases.

BiotechDigital HealthHealthtechMedical DevicesSingapore, SG

Brian Burke(Co-Founder and Advisor)inMark Kay(Co-Founder and Advisor)Colin Stewart(Co-Founder and Advisor)Yann Chong Tan(Co-Founder and Advisor)inMonica Shah(Chief Medical Officer)inAl Gianchetti(Chief Executive Officer)in

Co-investorsAngelini VenturesKurma PartnersBoehringer Ingelheim Venture FundHighlight CapitalSEEDS Capital

Paratus Sciences is a drug discovery company that uses AI-powered methods to identify first-in-class medicines by studying evolutionary traits, targeting serious diseases where current therapies are inadequate.

AI & Machine LearningBiotechDeep TechUnited States, US

Co-investorsARCH Venture PartnersEcoR1 Capital

Polaris Partners is an investment firm with nearly 30 years of experience backing healthcare and biotech companies, focusing on innovative care delivery, digital health, consumer-centric businesses, therapeutics, and genomics.

BiotechDigital HealthHealthtech

Generative AI-powered digital health platform providing personalized interventions for stress, anxiety, insomnia, and mental health challenges.

Rejoni is a company focused on uterine health, developing technology to address women's reproductive and gynecological health needs.

BiotechFemTechHealthtechMedical DevicesBedford, US

AMARPREET SAWHNEY(Executive Officer, Director, Promoter)inAmar Sawhney(Founder)inNICK SVENCER(Executive Officer, Director, Promoter)FARHAD KHOSRAVI(Executive Officer, Director, Promoter)

BoardTARA BUTLER(Executive Officer, Director, Promoter)

Co-investorsAscension VenturesDelos CapitalFemHealth VenturesIyengar Capital PartnersAmed VenturesCatalyst Health Ventures

Venture capital firm with offices in Japan and the United States focusing on company creation based on innovative science and early-stage products.

AI/ML health tech company building clinically-validated artificial intelligence for measuring and tracking disease progression across healthcare settings.

Biotechnology company developing blood-based diagnostic tests for neurological disorders and early-stage cancer.

Co-investorsARCH Venture Partners